Description This issue of the Rheumatic Disease Clinics of North America brings the rheumatologist up to date on the latest breakthroughs in the assessment
and treatment of fibromyalgia. Topics covered include fibromyalgia and central sensitization disorders; neurobiology/pathophysiology
of fibromyalgia; genetics and socioenvironmental influences; neuroimaging; dysautonomia; sleep; cognition; fibromyalgia in children and
adolescents; key symptom domains to be assessed in fibromyalgia; patient-reported outcome measures; nonpharmacologic therapy, including
exercise, cognitive behavioral, biofeedback, acupuncture, CAM, and nutrition; pharmacotherapy; and pathophysiology and practical treatment
paradigms.
